Synthetic Cannabinoid Addiction Treatment (Spice, K2)

Addiction to synthetic cannabinoids is one of the most unpredictable and dangerous substance use disorders. Substances known as Spice or K2 can trigger severe psychiatric disturbances, acute psychosis, seizures and life-threatening complications even after a single use. Treatment requires urgent inpatient medical and psychiatric care.

As part of our clinical approach to drug addiction treatment, we offer an individualised inpatient programme for patients with synthetic cannabinoid dependency. All clinical contact is confidential and non-binding.

What are synthetic cannabinoids (Spice, K2)

Synthetic cannabinoids are a group of illegal, laboratory-modified chemical substances that act on cannabinoid receptors in the brain, often many times more powerfully than THC. Despite colloquial names such as "synthetic marijuana", these substances are not marijuana. They have unpredictable compositions, often contain mixtures of multiple compounds, and are not subject to any quality control. Their clinical effects are far more toxic and dangerous than those of natural cannabis.

When urgent medical attention is required

Urgent medical attention is required if any of the following occur during withdrawal: seizures, loss of consciousness, severe disorientation, symptoms of psychosis, aggressive behaviour disproportionate to the situation, severe chest pain, shortness of breath or suspected overdose. In these situations, no attempt should be made to manage the condition independently. Patient safety and rapid clinical assessment are always the priority. In any life-threatening or health-threatening situation, emergency services should be contacted immediately by calling 112.

Why synthetic cannabinoids are exceptionally dangerous

Unlike THC, synthetic cannabinoids strongly and persistently activate CB1 receptors, can act neurotoxically, frequently trigger acute psychotic disturbances and cause severe somatic reactions. The composition of any given batch can vary dramatically, making the risk of overdose and sudden complications extremely high.

How Spice and K2 addiction develops

Addiction can develop very rapidly, sometimes after just a few uses. The mechanism involves intense stimulation of the reward system, rapid disorganisation of emotional regulation, rapid development of tolerance and severe psychological symptoms when cessation is attempted. For many patients, synthetic cannabinoids become the primary means of coping with tension, anxiety or emotional emptiness.

Symptoms of synthetic cannabinoid addiction

Psychological symptoms

• acute anxiety and panic states
• delusions and hallucinations
• disorientation and depersonalisation
• aggression or extreme apathy
• disturbances of consciousness
• suicidal or paranoid thoughts

Physical symptoms

• seizures
• vomiting and dehydration
• tachycardia and hypertension
• hyperthermia
• respiratory disturbances
• loss of consciousness

Behavioural symptoms

• sudden personality changes
• loss of behavioural control
• social isolation
• impulsivity and risk-taking behaviour
• repeated hospitalisations or emergency interventions

Health risks and complications

Use of synthetic cannabinoids is associated with the risk of acute psychosis requiring hospitalisation, permanent psychiatric disorders, nervous system damage, rhabdomyolysis and renal failure, and sudden death. Clinical literature also documents deaths in young people with no prior medical history.

Why inpatient treatment is indicated

In the case of substance use disorders involving synthetic cannabinoids, outpatient treatment is in most cases insufficient and carries a high risk. Treatment is therefore provided within a specialist drug addiction treatment programme under inpatient conditions. Inpatient treatment enables an immediate response to psychosis, round-the-clock medical supervision, safe symptomatic treatment, separation from the substance, and neurological and psychiatric assessment.

Synthetic cannabinoid addiction treatment at Zeus Detox & Rehab

Treatment is provided on an inpatient basis with patient safety as the priority.

In cases of acute psychosis resistant to pharmacological treatment, the patient may be transferred to an intensive care unit or closed psychiatric ward in accordance with safety standards.

When inpatient treatment for Spice and K2 addiction is indicated

For whom inpatient treatment may be appropriate

• individuals using Spice or K2
• recurrent psychotic episodes or disorganisation
• risk to health or life
• ineffectiveness of outpatient treatment

When another level of care is required

• acute psychosis requiring a closed psychiatric ward
• immediate risk to life
• absence of consent to inpatient treatment

Every decision is preceded by an individual clinical assessment.

Scope of treatment and clinical responsibility

Residential treatment focuses on medical stabilisation, evaluation of the patient's psychological state and intensive therapeutic work in the acute or advanced phase of the disorder. It does not replace long-term outpatient treatment and does not guarantee any specific clinical outcome. Planning of further care is an integral part of the therapeutic process.